|
× |
 |
Novel Antipsychotic Use in Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Reflections on Perinatal Depression Treatment PDF |
$40.00 |
|
$40.00 |
|
× |
|
Delusional Infestation With Black Mold Presenting to the General Hospital PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effect of Reboxetine on Depression in Parkinson's Disease Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Sublingual Ketamine for Rapid Relief of Suicidal Ideation PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Same or Different? A Phenomenological Comparison of Auditory Verbal Hallucinations in Healthy and Psychotic Individuals PDF |
$40.00 |
|
$40.00 |
|
× |
|
Neurocognitive Effects of Neurofeedback in Adolescents With ADHD: A Randomized Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clomipramine Treatment of Panic Disorder: Pros and Cons PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors PDF |
$40.00 |
|
$40.00 |
|
× |
|
Mitigation of Anxiety, Agitation, and Pain in Critically Ill Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clinical Features Distinguishing Patients With Tourette's Syndrome and Obsessive-Compulsive Disorder From Patients With Obsessive-Compulsive Disorder Without Tics PDF |
$40.00 |
|
$40.00 |
|
× |
|
Safety of Available Agents Used to Treat Bipolar Disorder: Focus on Weight Gain PDF |
$40.00 |
|
$40.00 |
|
× |
|
Correlation Between Different Levels of Placebo Response Rate and Clinical Trial Outcome in Major Depressive Disorder: A Meta-Analysis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Buspirone for Comorbid Anxiety in Autism PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases PDF |
$40.00 |
|
$40.00 |
|
× |
|
Camptocormia and Antipsychotic Medications PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Course of Eating Disorders During COVID-19 PDF |
$40.00 |
|
$40.00 |
|
× |
|
Trajectories of Perinatal Depressive and Anxiety Symptoms in a Community Cohort PDF |
$40.00 |
|
$40.00 |
|
× |
|
Response to Past Depression Treatments Is Not Accurately Recalled: Comparison of Structured Recall and Patient Health Questionnaire Scores in Medical Records PDF |
$40.00 |
|
$40.00 |
|
× |
|
Mortality and Suicide Related to Major Depressive Disorder Before and After Type 2 Diabetes Mellitus PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II) PDF |
$40.00 |
|
$40.00 |
|
× |
|
Impact of CYP1A2 and CYP2D6 Polymorphisms on Drug Metabolism and on Insulin and Lipid Elevations and Insulin Resistance in Clozapine-Treated Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Reduction of Opioid-Withdrawal Symptoms With Quetiapine PDF |
$40.00 |
|
$40.00 |
|
|
